Home LiteratureArticle Details
PMID: 9066012 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.

Thrombosis and haemostasis ·Vol. 77 ·No. 3 ·1997-03-00 ·Pages 568-76

Frojmovic MM, Kasirer-Friede A, Goldsmith HL, Brown EA

Abstract

We previously showed that ADP activation of washed human platelets in plasma-free suspensions supports aggregation at moderate shear stress (0.4-1.6 Nm-2) in Poiseuille flow. Although most activated platelets expressed maximal fibrinogen-occupied GPIIb-IIIa receptors, aggregation appeared to be independent of bound fibrinogen, but blocked by the hexapeptide GRGDSP. Here, we tested the hypothesis that von Willebrand factor (vWF) secreted and expressed on activated platelets mediates aggregation at moderate shear rates from 300 to 1000 s-1 corresponding to shear stresses from 0.3 to 1.1 Nm-2. Relatively unactivated platelets (< 15% expressing prebound fibrinogen) were prepared from acidified citrated platelet rich plasma (cPRP) by single centrifugation with 50 nM stable prostacyclin derivative ZK 36374 and resuspended in Tyrodes-albumin at 5 x 10(4) cells microliter-1. Flow cytometric measurements with monoclonal antibody (mAb) 2.2.9 reporting on surface-bound vWF, and with mAb S12 reporting on alpha-granule secreted P-selectin, showed that 65% and 80%, respectively, of all platelets were maximally activated with respect to maximal secretion and surface expression of these proteins. "Resting" washed platelets exhibited both surface-bound vWF and significant P-selectin secretion. We showed that mAbs 6D1 and NMC4, respectively blocking the adhesive domains on the GPIb receptor recognizing vWF, and on the vWF molecule recognizing the GPIb receptor, partially inhibited ADP-induced aggregation under shear in Couette flow, the degree of inhibition increasing with increasing shear stress. In contrast, mAb 10E5, blocking the vWF binding domain on GPIIb-IIIa, essentially blocked all aggregation at the shear rates tested. We conclude that vWF, expressed on ADP-activated platelets, is at least the predominant cross-bridging molecule mediating aggregation at moderate shear stress. There is an absolute requirement for free activated GPIIb-IIIa receptors, postulated to interact with platelet-secreted, surface bound vWF. The GPIb-vWF cross-bridging reaction plays a facilitative role becoming increasingly important with increasing shear stress. Since aurin tricarboxylic acid, which blocks the GPIb binding domain on vWF, was also found to completely block aggregation in Poiseuille flow, we conclude that it too affects the GPIIb-IIIa interaction.

MeSH Terms
Adenosine Diphosphate/pharmacology Antibodies, Monoclonal/immunology Blood Platelets/drug effects Fibrinogen/analysis Flow Cytometry Humans Platelet Activation Platelet Aggregation Platelet Glycoprotein GPIIb-IIIa Complex/pharmacology Platelet Glycoprotein GPIb-IX Complex/metabolism Surface Properties von Willebrand Factor/metabolism
Chemicals
Antibodies, Monoclonal Platelet Glycoprotein GPIIb-IIIa Complex Platelet Glycoprotein GPIb-IX Complex von Willebrand Factor Adenosine Diphosphate Fibrinogen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Frojmovic M M
Departments of Physiology and Medicine, McGill University, Montreal, Canada. [email protected]
Kasirer-Friede A
Goldsmith H L
Brown E A
Article Info
Journal
Thrombosis and haemostasis
Abbr.
Thromb Haemost
ISSN
0340-6245
Published
1997-03-00
Pages
568-76
Language
English
Region
Germany
NLM ID
7608063
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]